Beyond Diabetes: Abbott Launches Glucose Sport Biosensor For Athletes To Track Blood Sugar
Executive Summary
Analyst Larry Biegelsen expects Abbott’s CGM move into the consumer market could open a large new marketing opportunity.
You may also be interested in...
JPM 2021: Boston Scientific, Abbott, Dexcom, Insulet, Silk Road Medical
The annual J.P. Morgan Healthcare Conference includes presentations from many major medtech companies outlining their growth strategies and expectations for 2021. Here are some of the highlights from the second day of the meeting.
Abbott’s 3Q $8.9Bn Sales Beat Wall Street Consensus, Medtech Sales Up 3.4%
Abbott reported strong sales for diagnostics and devices in the third quarter and raised its full-year EPS guidance to $3.55 per share.
Abbott Surprises Analysts With CE Mark For Freestyle Libre 3
The new continuous glucose sensor is the smallest and thinnest in the world, according to Abbott.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: